Nav: ₹ 43.789 ↑ 0.4%
[as on 11 September, 2025]
Nav chart with 500 day SMA
SMA
- 100 SMA
- 200 SMA
- 300 SMA
- 400 SMA
- 500 SMA
Returns
| Name | YTD | 1D | 1W | 1M | 3M | 1Y | 3Y | 5Y | 7Y | 10Y |
|---|---|---|---|---|---|---|---|---|---|---|
| Mirae Asset Healthcare Fund Direct Growth | -0.29% | 0.4% | 1.72% | 3.1% | 3.65% | 2.59% | 23.61% | 20.91% | 21.92% | - |
Portfolio
Equity
| Name | Sector | Weight % |
|---|---|---|
| Sun Pharmaceutical Industries Ltd. | Pharmaceuticals & Biotechnology | 10.92 % |
| Divi's Laboratories Ltd. | Pharmaceuticals & Biotechnology | 8.15 % |
| Glenmark Pharmaceuticals Ltd. | Pharmaceuticals & Biotechnology | 6.79 % |
| Apollo Hospitals Enterprise Ltd. | Healthcare Services | 6.32 % |
| Cipla Ltd. | Pharmaceuticals & Biotechnology | 6.30 % |
| Aurobindo Pharma Ltd. | Pharmaceuticals & Biotechnology | 6.02 % |
| Lupin Ltd. | Pharmaceuticals & Biotechnology | 4.94 % |
| Dr. Reddy's Laboratories Ltd. | Pharmaceuticals & Biotechnology | 4.27 % |
| Fortis Healthcare Ltd. | Healthcare Services | 3.89 % |
| Krishna Institute of Medical Sciences Ltd. | Healthcare Services | 3.82 % |
| IPCA Laboratories Ltd. | Pharmaceuticals & Biotechnology | 3.44 % |
| Aster DM Healthcare Ltd. | Healthcare Services | 3.33 % |
| Cohance Lifesciences Ltd. | Pharmaceuticals & Biotechnology | 3.27 % |
| JB Chemicals & Pharmaceuticals Ltd. | Pharmaceuticals & Biotechnology | 2.77 % |
| Torrent Pharmaceuticals Ltd. | Pharmaceuticals & Biotechnology | 2.75 % |
| Alkem Laboratories Ltd. | Pharmaceuticals & Biotechnology | 2.70 % |
| Onesource Specialty Pharma Ltd. | Pharmaceuticals & Biotechnology | 2.50 % |
| Eris Lifesciences Ltd. | Pharmaceuticals & Biotechnology | 2.36 % |
| Laurus Labs Ltd. | Pharmaceuticals & Biotechnology | 2.30 % |
| Sai Life Sciences Ltd. | Pharmaceuticals & Biotechnology | 2.22 % |
| Wockhardt Ltd. | Pharmaceuticals & Biotechnology | 1.74 % |
| Mankind Pharma Ltd. | Pharmaceuticals & Biotechnology | 1.62 % |
| Gland Pharma Ltd. | Pharmaceuticals & Biotechnology | 1.57 % |
| Anthem Biosciences Ltd. | Pharmaceuticals & Biotechnology | 1.54 % |
| Biocon Ltd. | Pharmaceuticals & Biotechnology | 0.93 % |
| Sagility India Ltd. | IT - Services | 0.83 % |
| Deepak Nitrite Ltd. | Chemicals & Petrochemicals | 0.79 % |
| Neogen Chemicals Ltd. | Chemicals & Petrochemicals | 0.52 % |
| Syngene International Ltd. | Healthcare Services | 0.51 % |
| Laxmi Dental Ltd. | Healthcare Equipment & Supplies | 0.50 % |
Debt
| Name | Rating | Weight % |
|---|---|---|
| Mirae Asset Liquid Fund-Direct Plan-Growth | 0.01 % |
Portfolio data is as on date 31 August, 2025
FAQ (Frequently asked questions)
What is latest/current NAV/price of Mirae Asset Healthcare Fund Direct Growth?
The latest NAV of Mirae Asset Healthcare Fund Direct Growth is 43.789 as on 11 September, 2025.What are YTD (year to date) returns of Mirae Asset Healthcare Fund Direct Growth?
The YTD (year to date) returns of Mirae Asset Healthcare Fund Direct Growth are -0.29% as on 11 September, 2025.What are 1 year returns of Mirae Asset Healthcare Fund Direct Growth?
The 1 year returns of Mirae Asset Healthcare Fund Direct Growth are 2.59% as on 11 September, 2025.What are 3 year returns of Mirae Asset Healthcare Fund Direct Growth?
The 3 year annualized returns of Mirae Asset Healthcare Fund Direct Growth are 23.61% as on 11 September, 2025.What are 5 year returns of Mirae Asset Healthcare Fund Direct Growth?
The 5 year annualized returns of Mirae Asset Healthcare Fund Direct Growth are 20.91% as on 11 September, 2025.